Sunday, March 15, 2026

JW Pharmaceutical Advances Gout Treatment with Epaminurad

JW Pharmaceutical advances its gout treatment, Epaminurad, with global trials nearing completion and U.S. patent secured for market entry.

NIS Reports: 3,000 North Korean Troops in Russia, 10,000 More to Follow

South Korea's NIS reports North Korea has sent 3,000 troops to Russia, expecting an additional 10,000 by December.

Kim Jong-un Attends New Year Event With Ju-ae “Continue To Struggle This Year”

Kim Jong Un praised the people's efforts during the 2026 New Year Celebration in Pyongyang, emphasizing unity and patriotism for the new year.

Nikola’s Stock Makes a Comeback—But Will It Last?

EtcNikola's Stock Makes a Comeback—But Will It Last?
Yahoo Finance
Yahoo Finance

Nikola’s stock, teetering on the brink of bankruptcy, remains on a wild ride, swinging dramatically between gains and losses on Wall Street.

On Tuesday, shares soared 41.44%, closing at 76 cents on the New York Stock Exchange.

This sharp rebound followed a 10.30% drop just last Friday.

Despite its daily volatility, the stock has surged 52.87% over the past five trading sessions.

Analysts attribute this extreme price movement to speculative traders betting on Nikola’s uncertain future. With shares already below $1, the downside risk appears limited, while the potential upside could be substantial if the company avoids bankruptcy.

As speculation continues to fuel Nikola’s stock, investors should brace for more sharp price swings in the days ahead.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles